CN102579104A - Exclusion surgery device for duodenum and upper jejunum - Google Patents

Exclusion surgery device for duodenum and upper jejunum Download PDF

Info

Publication number
CN102579104A
CN102579104A CN2012100952814A CN201210095281A CN102579104A CN 102579104 A CN102579104 A CN 102579104A CN 2012100952814 A CN2012100952814 A CN 2012100952814A CN 201210095281 A CN201210095281 A CN 201210095281A CN 102579104 A CN102579104 A CN 102579104A
Authority
CN
China
Prior art keywords
film
fluororesin tube
exclusion
duodenum
shaped
Prior art date
Application number
CN2012100952814A
Other languages
Chinese (zh)
Inventor
周怀其
彭文涛
曾延华
李赛斯
窦允冲
陈旭东
Original Assignee
湖南依微迪医疗器械有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 湖南依微迪医疗器械有限公司 filed Critical 湖南依微迪医疗器械有限公司
Priority to CN2012100952814A priority Critical patent/CN102579104A/en
Publication of CN102579104A publication Critical patent/CN102579104A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/0076Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/045Stomach, intestines

Abstract

The invention discloses an exclusion surgery device for duodenum and upper jejunum. The device is formed by connecting a first and a second membrane-like fluororesin tube with different diameters. The first membrane-like fluororesin tube with larger diameter is provided inside with a stent, which is fixed to an inner surface of the first membrane-like fluororesin tube by terylene suture and made of stainless steel wire or nickel-titanium shape memory alloy wire. The second membrane-like fluororesin tube has length of 55-70cm. The invention can treat obesity and adult diabetes, and obviate unnecessary influence of surgical operation on human body. The exclusion surgery device disclosed by the invention has definite curative effect on obesity and adult diabetes and little complication proved by clinical test.

Description

十二指肠空肠上段旷置装置 Duodenum, upper jejunum exclusion means

技术领域 FIELD

[0001] 本发明涉及一种用于治疗肥胖、成人型糖尿病的装置,特别涉及一种十二指肠空肠上段旷置装置。 [0001] The present invention relates to a method for obesity, diabetes adult treatment apparatus, particularly to a duodenum, upper jejunum exclusion means.

背景技术 Background technique

[0002] 肥胖已经是全球性范围的公共卫生问题,国际肥胖特别工作组(TOTF)指出,肥胖已经成为一种流行病,而且一直严重威胁我们的健康,肥胖将成为21世纪威胁人类健康和生活满意度的最大杀手。 [0002] Obesity is a public health problem has a global scope, the International Obesity Task Force (TOTF) pointed out that obesity has become an epidemic, and has been a serious threat to our health, obesity will become a threat to human health and life in the 21st century the biggest killer of satisfaction. 当机体内摄入食物中所含的能量大于机体的消耗量,多余的这部分就会以脂肪的形式储存在体内,久而久之,体重就可能超出正常的体重标准,或造成体内脂肪堆积过多,导致体重超常。 When the consumption of energy intake of food contained in the body is greater than the body, the excess will be stored as part of this fat in the body, over time, may exceed the body weight of normal weight standards, or cause excessive accumulation of body fat, lead to overweight.

[0003] 肥胖还易并发其他疾病,如肥胖者的高血压发病率达50%左右。 [0003] Obesity is also complicated by other diseases such as obesity hypertension rate of about 50%. 由于肥胖症患者常有高胆固醇血症,血脂也高,而血脂中具有明显保护血管作用的高密度脂蛋白-胆固醇浓度降低,而低密度脂蛋白-胆固醇则增高,这就有利于胆固醇在冠状动脉管壁的沉积,形成冠心病,导致肥胖人中高血压病并发脑出血的发病年龄也越来越向前推移。 Because obese patients often have high cholesterol, high blood lipids also, and lipids in the blood vessels has protective effect of high density lipoprotein - lowering cholesterol levels, and low density lipoprotein - cholesterol is increased, which is conducive to cholesterol in the coronary arterial wall deposition, coronary heart disease, leading to obesity among hypertensive patients complicated with cerebral hemorrhage age are increasingly onward. 肥胖人的心脏病突发危险也明显增加。 Obese people are also significantly increased the risk of heart attack. 一些慢性疾病如胆道结石、关节炎、静脉血栓形成、慢性支气管炎等的发病率在肥胖病人中也较正常人更多见。 Some chronic diseases such as biliary stones, arthritis, venous thrombosis, the incidence of chronic bronchitis also more common than normal in obese patients. 肥胖人增多还会带来不少社会问题,如肥胖人不适宜从事某些工种和职业;肥胖还会带来种种心理问题,这在儿童身上表现更为突出,如因他人取笑而拒绝参加社会活动和少交朋友,产生孤独感,由于肢体活动不灵活,也拒绝参加各种体育活动,形成“越不活动就越胖”的不良循环。 Obese people increase will bring a lot of social problems, such as obesity people unfit for certain jobs and career; obesity will bring a variety of psychological problems, as demonstrated in children is more prominent, as a result of making fun of others and refused to participate in society activities and pay less with friends, a sense of loneliness, due to the physical activities are not flexible, but also refused to participate in various sports activities, the formation of "the more inactive the more fat," the vicious circle.

[0004] 肥胖也易于发生糖尿病,有人曾调查了1000名糖尿病患者发病前的体重,在标准体重以下者仅占8%,标准体重者占15%,超过标准体重者达77%。 [0004] Obesity is also easy to diabetes, some have investigated the body weight before the onset of diabetes 1000, the standard weight of age accounted for only 8% of the standard weight, 15% more than the standard weight of 77%.

[0005] 医学界认为当体重超过体重标准的10%时,称为超重;超出标准体重的20%,称为轻度肥胖;超出标准体重的30%时候,称为中度肥胖;当超过50%时候称为重度肥胖。 [0005] When the medical profession that the body weight exceeds 10% of the standard, known as overweight; 20% above normal body weight, referred to mildly obese; standard weight exceeds 30% of the time, referred to moderately obese; when more than 50 % time called severe obesity.

[0006]目前国内外流行的具有肯定疗效的外科治疗肥胖的方法有空回肠短路手术、胆管胰腺短路手术、胃短路手术、胃成形术、迷走神经切断术及胃气囊术,其中以腹腔镜下肠道改道手术被认为疗效最可靠,并发症最少。 [0006] popular at home and abroad obesity surgical treatment has a positive effect free method ileal bypass operation, short circuit biliary pancreatic surgery, gastric bypass surgery, gastroplasty, vagotomy surgery and gastric balloon surgery, in which the laparoscopic bowel Road bypass surgery is considered the most reliable efficacy, minimal complications. 由于胃肠改道,食物将不通过十二指肠和空肠上段,而直接进入空肠下段和回肠,身体对食物的吸收面积大大减少,身体能量吸收的作用得到很大的限制,餐后急剧的血糖波动和消化道原本因食物刺激而出现急剧的消化液分泌得以控制,也更进一步强化了限制食物中能量吸收的作用。 Because of gastrointestinal diversion, food will not pass through the duodenum and upper jejunum, and direct access to the lower jejunum and ileum, the body's absorption of food is greatly reduced area, the body energy absorption role has been greatly restricted, sharp postprandial blood glucose fluctuations in food and digestive tract originally due to a sharp stimulation of secretion of digestive juice can be controlled, but also further strengthen the food restrictions in energy absorption effect. 胆囊及胰腺也因旁路手术后,食物不再通过十二指肠和空肠上段,其受食物直接刺激而反射性引起的负担减轻,从而达到了减肥和成人型糖尿病得以控制的效果。 After the gallbladder and pancreas also because bypass surgery, no food through the duodenum and upper jejunum, food borne directly by the stimulation caused by reflex reduction, so as to achieve the effect of diet and adult diabetes is controlled. 由于需经外科手术建立胃肠改道,除会引起外科手术导致场粘连、腹痛外,治疗一段时间后,如需要重新恢复到原有的胃肠,则必需再次外科手术才能完成。 Due to the need to establish re-routed via the gastrointestinal surgery, in addition to surgery can cause adhesions lead to field, abdominal pain, after a period of treatment, such as the need to restore the original GI, it is necessary to complete the surgery again.

发明内容 SUMMARY

[0007] 为了解决现有外科治疗肥胖存在的上述技术问题,本发明提供一种用于治疗肥胖、成人型糖尿病的十二指肠空肠上段旷置装置。 [0007] To solve the above problems of the conventional surgical treatment of obesity, the present invention provides a method for treating obesity, diabetes adult duodenum jejunum exclusion means. 本发明能无创且选择性地在胃与空肠下段间形成一过性的旁路,使十二指肠和空肠上段在进食和消化吸收过程中不起作用,从而使得治疗肥胖和成人型糖尿病疗效可靠,并发症少。 The present invention is noninvasive and can be selectively formed in a transient gastric bypass and lower jejunum, duodenum and upper jejunum does not work in the process of digestion and absorption of food and so that the efficacy of treatment of obesity and diabetes adult reliable, with few complications.

[0008] 本发明解决上述技术问题的技术方案是:由不同直径的第一膜状氟树脂管、第二膜状氟树脂管连接而成,直径较大的第一膜状氟树脂管内设有支架,并用涤沦缝线固定于第一膜状氟树脂管内表面。 [0008] The technical problem to solve the above technical solution of the present invention is: a first film-shaped fluororesin tubes of different diameters, the second film-shaped fluororesin tube connected together, a first larger diameter pipe equipped with a film-shaped fluororesin stents, sutures and fixed to the polyester fiber with the inner surface of the first film-shaped fluororesin tube.

[0009] 上述的十二指肠空肠上段旷置装置中,所述支架为齿状或网状。 [0009] The duodenum jejunum exclusion apparatus, the stent is a mesh or toothed.

[0010] 上述的十二指肠空肠上段旷置装置中,所述支架采用不锈钢丝或镍钛记忆合金丝制成。 [0010] The duodenum jejunum exclusion device, or a stent made of stainless steel wire made of nitinol wire.

[0011] 上述的十二指肠空肠上段旷置装置中,所述第二膜状氟树脂管的长度为55-70cm。 [0011] The duodenum jejunum exclusion apparatus, the length of the second film-shaped fluororesin tube is 55-70cm.

[0012] 与现有技术相比,本发明的技术效果在于:本发明通过非外科手术的方法,使胃和空肠上段得到“旷置”,即绕过十二指肠和空肠上段,使消化道出现改道,食物在进食后,直接经胃进入空肠下段,使十二指肠和空肠上段在进食和消化吸收过程中不起作用,那么食物可直接经胃而直接进入空肠下段,同样可达到原本需要手术才能实现的身体体内消化吸收面积大大减少、消化道分泌物减少、胆囊和胰腺的负担减轻的作用,达到治疗肥胖和成人型糖尿病的目的。 [0012] Compared with the prior art, the technical effect of the present invention is that: the present invention by a method of non-surgical procedures, the stomach and the upper jejunum obtained "exclusion", i.e. bypassing the duodenum and upper jejunum, digestive Road diversion occurs, after eating food directly into the stomach through the lower jejunum, duodenum and upper jejunum not work in food digestion and absorption processes, it can be directly through the food directly into the stomach and lower jejunum, can achieve the same the role originally required surgery to achieve the body digest and absorb body area greatly reduced, to reduce gastrointestinal secretions, reduce the burden of the gallbladder and pancreas, to achieve the purpose of treatment of obesity and adult-onset diabetes. 当治疗达到目的后,同样又可通过无创的方法将本发明自体内取出,恢复患者原本的消化道状况,因而既可达到治疗目的,又免除了外科手术对人体的不必要影响。 After treatment purposes, but also the present invention is also removed from the body by means of non-invasive, the recovery of patients had gastrointestinal conditions, and thus can achieve therapeutic purposes, but also eliminates unnecessary surgery impact on the human body. 临床验证,本发明治疗肥胖和成人型糖尿病疗效可靠,并发症少。 Clinical tests, the efficacy of treatment of obesity and diabetes adult present invention is reliable, less complications.

附图说明 BRIEF DESCRIPTION

[0013] 图I为本发明的结构示意图。 [0013] structural diagram I of the present invention.

[0014] 图2为本发明的工作原理图。 [0014] FIG. 2 operating principle of the present invention.

具体实施方式 Detailed ways

[0015] 下面结合附图对本发明作进一步的说明。 [0015] The following drawings further illustrate the present invention in combination.

[0016] 如图I所示,本发明由不同直径的第一膜状氟树脂管I、第二膜状氟树脂管4连接而成,直径较大的第一膜状氟树脂管I内设有支架2,并用涤沦缝线3固定于第一膜状氟树脂管I内表面;支架2的形状为齿状,也可以采用其它的形状如网状等。 [0016] As shown in FIG I, the present invention is different from the diameter of the first film-shaped fluororesin tube I, the second film-shaped fluororesin tube 4 connected to each other, the first film-shaped larger diameter fluororesin tube I site a bracket 2, and 3 is fixed with dacron sutures in the first surface of the film-shaped fluororesin tube I; toothed shape of the holder 2, other shapes may be used, such as a mesh. 第一膜状氟树脂管I、第二膜状氟树脂管4可以采用一次成形工艺制作,第二膜状氟树脂管4的长度为在55-70cm范围,第一膜状氟树脂管的直径为5-6cm,第二膜状氟树脂管的直径为3. 5-4cm。 A first film-shaped fluororesin tube I, the second film-shaped fluororesin tube 4 may be made using a forming process, the length of the second film-shaped fluororesin tube 4 is in the range of 55-70cm diameter of the first film-shaped fluororesin tube is 5-6cm, diameter of the second film-shaped fluororesin tube is 3. 5-4cm. 支架2采用不锈钢丝或镍钛记忆合金丝制成。 Holder 2 made of stainless steel wire or wire made of nitinol.

[0017] 使用时,将本发明的第一膜状氟树脂管I固定在释放导丝的近端,第二膜状氟树脂管4向该固定点折叠压缩,第二膜状氟树脂管4的开口处固定在释放导丝的远端。 [0017] In use, the first film-shaped fluororesin tube I of the invention release the proximal end of the guidewire is fixed, the second film-shaped fluororesin tube 4 is folded to compress fixed point, the second film-shaped fluororesin tube 4 opening of the guidewire is fixed to the distal end of the release. 在胃镜观察下,先将释放导丝经幽门自十二指肠球部6向下输送。 Under endoscopic observation, by first releasing the guidewire from the duodenal pylorus 6 fed downward. 待固定装置的第一膜状氟树脂管I的释放导丝的近端到达十二指肠球部6时,释放第一膜状氟树脂管1,使其膨胀固定在十二指肠球部。 A first release film-shaped proximal guidewire I fluororesin tube means to be fixed reaches the duodenal portion 6, a first release film-shaped fluororesin tube 1, so that the expansion portion is fixed to the duodenal bulb . 继续向下输送释放导丝,当胃镜观察到第二膜状氟树脂管4的原折叠压缩部分的膜状氟树脂管全部释放后,将固定膜状氟树脂管开口出的固定点释放,即完成操作。 Further transport down to release the guidewire, the film-shaped when observed gastroscope fluororesin tube of the original film-shaped folded portion of the second compressed fluororesin tube 4 is fully released, the fixing film-shaped fluororesin tube opening out of the fixed-point release, i.e., to complete the operation. 空肠7上段被本发明的膜状氟树脂管覆盖,在下方的空肠7处可见膜状氟树脂管的开口8。 7 is a film-shaped upper jejunum segment covering the fluororesin tube of the present invention, the opening 7 at the bottom of the jejunum visible film-shaped fluororesin tube 8. 食物经本发明的膜状氟树脂管内向下流动,消化液体则在膜状氟树脂管外向下流动。 Food was within the film-shaped fluororesin tube of the present invention under flow, the liquid flows down digestion in the outer film-shaped fluororesin tube.

Claims (5)

1. 一种十二指肠空肠上段旷置装置,其特征是:由不同直径的第一膜状氟树脂管、第二膜状氟树脂管连接而成,直径较大的第一膜状氟树脂管内设有支架,并用涤沦缝线固定于第一膜状氟树脂管内表面。 An duodenum, upper jejunum exclusion apparatus, wherein: a first film-shaped fluororesin tubes of different diameters, the second film-shaped fluororesin tube connected together, the first film-like fluorine larger diameter holder equipped with the resin tube, and the polyester fiber with a suture secured in the first surface of the film-shaped fluororesin tube.
2.根据权利要求I所述的十二指肠空肠上段旷置装置,其特征是:所述支架为齿状或网状。 2. The upper segment exclusion apparatus according duodenojejunal I according to claim, wherein: said stent is a mesh or toothed.
3.根据权利要求2所述的十二指肠空肠上段旷置装置,其特征是:所述支架采用不锈钢丝或镍钛记忆合金丝制成。 3. The upper duodenojejunal exclusion apparatus according to claim 2, wherein: said stent wire or stainless steel wire made of nitinol.
4.根据权利要求I所述的十二指肠空肠上段旷置装置,其特征是:所述第一膜状氟树脂管的直径为5-6cm,第二膜状氟树脂管的直径为3. 5-4cm。 The upper exclusion duodenojejunal apparatus I according to claim, characterized in that: the diameter of the first film-shaped fluororesin tube is 5-6cm, diameter of the second film-shaped fluororesin tube is 3 . 5-4cm.
5.根据权利要求I所述的十二指肠空肠上段旷置装置,其特征是:所述第二膜状氟树脂管的长度为55-70cm。 Duodenojejunal according to claim I of the upper segment exclusion apparatus, wherein: a length of the second film-shaped fluororesin tube is 55-70cm.
CN2012100952814A 2012-04-01 2012-04-01 Exclusion surgery device for duodenum and upper jejunum CN102579104A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012100952814A CN102579104A (en) 2012-04-01 2012-04-01 Exclusion surgery device for duodenum and upper jejunum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012100952814A CN102579104A (en) 2012-04-01 2012-04-01 Exclusion surgery device for duodenum and upper jejunum

Publications (1)

Publication Number Publication Date
CN102579104A true CN102579104A (en) 2012-07-18

Family

ID=46468736

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012100952814A CN102579104A (en) 2012-04-01 2012-04-01 Exclusion surgery device for duodenum and upper jejunum

Country Status (1)

Country Link
CN (1) CN102579104A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014161446A1 (en) * 2013-03-31 2014-10-09 Wan Ping Duodenal internal covering membrane

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101843536A (en) * 2010-04-09 2010-09-29 张发明;南京医科大学第二附属医院 Duodenal sleeve and conveyor thereof
CN201987704U (en) * 2010-12-06 2011-09-28 北京畅想天行医疗技术有限公司 Duodenum-jejunum built-in cannula
EP2397113A1 (en) * 2001-08-27 2011-12-21 Synecor, LLC Satiation devices

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397113A1 (en) * 2001-08-27 2011-12-21 Synecor, LLC Satiation devices
CN101843536A (en) * 2010-04-09 2010-09-29 张发明;南京医科大学第二附属医院 Duodenal sleeve and conveyor thereof
CN201987704U (en) * 2010-12-06 2011-09-28 北京畅想天行医疗技术有限公司 Duodenum-jejunum built-in cannula

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014161446A1 (en) * 2013-03-31 2014-10-09 Wan Ping Duodenal internal covering membrane
GB2527999A (en) * 2013-03-31 2016-01-06 Ping Wan Duodenal internal covering membrane
AU2014247462B2 (en) * 2013-03-31 2017-03-02 Ping Wan Duodenal internal covering membrane
US9918862B2 (en) 2013-03-31 2018-03-20 Ping Wan Internal covering membrane of duodenum

Similar Documents

Publication Publication Date Title
Elder et al. Bariatric surgery: a review of procedures and outcomes
US6946002B2 (en) Intragastric stent for duodenum bypass
US7037344B2 (en) Apparatus and methods for treatment of morbid obesity
JP5393831B2 (en) Obesity therapeutic sleeve
US20080249533A1 (en) Medical Device and Method For Controlling Obesity
JP5216053B2 (en) Intestinal sleeve
Loffredo et al. Three Years Experience with the New Intragastric Balloon, and A Preoperative Test for Success witb Restrictive Surgery
JP2012522595A (en) Artificial organs for modular digestive tract
JP2009538690A (en) Anti-obesity stent
CN101076289A (en) Transesophageal gastric reduction device, system and method
US9149614B2 (en) Systems and methods for treatment of obesity and type 2 diabetes
US20080221597A1 (en) Methods and devices for intragastrointestinal fixation
JPH09501677A (en) Method of modulating the sexual response in humans
KR20060046305A (en) A surgically implantable injection port having an improved fastener
CN1838978A (en) Gastrointestinal methods and apparatus for use in treating disorders
Moss Floating kidneys: a century of nephroptosis and nephropexy
US8226593B2 (en) Pyloric valve
JP2014533981A (en) Intragastric implant device
CN105431195B (en) System and method for electrical stimulation to treat anorectal structure anal dysfunction
US8475401B2 (en) Systems and methods for treating obesity and type 2 diabetes
US8403877B2 (en) Systems and methods for treatment of obesity and type 2 diabetes
US9037245B2 (en) Endoscopic lead implantation method
WO2008031474A1 (en) Device for treating obsesity
JP5300031B2 (en) Stent
CN101843536B (en) Duodenal sleeve and conveyor thereof

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)